Topical vs Systemic Therapy in Psoriasis: Escalating Wisely in the Biologic Era Review Abstract Purpose: This review examines how clinicians should decide among optimized topical therapy, phototherapy, oral systemic treatment, and biologic therapy in plaque psoriasis. Methodology: Review of recent clinical guidelines, FDA prescribing information,
Tag: plaque psoriasis
Guselkumab Provides Relief For Patients Who Suffer With Psoriasis
Guselkumab Provides Relief For Patients Who Suffer With Psoriasis Overview A 52-week postmarketing surveillance study was launched to assess the safety and effectiveness of guselkumab, a human monoclonal antibody targeting the interleukin-23 subunit p19, in Japanese patients diagnosed with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis in real-world clinical
Piclidenoson In The Treatment Of Plaque Psoriasis
Piclidenoson In The Treatment Of Plaque Psoriasis Overview The study focused on evaluating the effectiveness and safety of piclidenoson (CF101), an orally bioavailable agonist for the A3 adenosine receptor (A3AR), in treating moderate-to-severe plaque psoriasis. The A3AR is known to be overexpressed in the skin and peripheral blood mononuclear cells of individuals
